Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Arnesen

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|March 16, 2006
Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly menM Trøseid, E M Hjerkinn, I Seljeflot, et al.
Journal of Clinical Microbiology|April 28, 2001
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individualsA Schumacher, A B Lerkerød, I Seljeflot, et al.
European Journal of Clinical Investigation|January 11, 2005
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosisS L Seierstad, I Seljeflot, O Johansen, et al.
Diabetologia|March 11, 2005
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetesJ R Larsen, M Brekke, L Bergengen, et al.
Clinical Biochemistry|April 17, 2004
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemiaM A Mansoor, I Seljeflot, H Arnesen, et al.
JRSM Cardiovascular Disease|September 22, 2017
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional studyK Laake, I Seljeflot, E B Schmidt, et al.
Thrombosis Research|January 26, 2005
Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendationsE B Schmidt, H Arnesen, J H Christensen, et al.
Vascular Medicine (London, England)|May 4, 2006
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive diseaseM Nylaende, A Kroese, E Stranden, et al.
Vascular Medicine (London, England)|December 1, 2007
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) studyM Nylaende, A J Kroese, B Morken, et al.
Heart (British Cardiac Society)|October 17, 2009
Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled studyJ O Beitnes, E Hopp, K Lunde, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Scandinavian Journal of Clinical and Laboratory Investigation|March 16, 2006
Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly menM Trøseid, E M Hjerkinn, I Seljeflot, et al.
Journal of Clinical Microbiology|April 28, 2001
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individualsA Schumacher, A B Lerkerød, I Seljeflot, et al.
European Journal of Clinical Investigation|January 11, 2005
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosisS L Seierstad, I Seljeflot, O Johansen, et al.
Diabetologia|March 11, 2005
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetesJ R Larsen, M Brekke, L Bergengen, et al.
Clinical Biochemistry|April 17, 2004
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemiaM A Mansoor, I Seljeflot, H Arnesen, et al.
JRSM Cardiovascular Disease|September 22, 2017
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional studyK Laake, I Seljeflot, E B Schmidt, et al.
Thrombosis Research|January 26, 2005
Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendationsE B Schmidt, H Arnesen, J H Christensen, et al.
Vascular Medicine (London, England)|May 4, 2006
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive diseaseM Nylaende, A Kroese, E Stranden, et al.
Vascular Medicine (London, England)|December 1, 2007
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) studyM Nylaende, A J Kroese, B Morken, et al.
Heart (British Cardiac Society)|October 17, 2009
Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled studyJ O Beitnes, E Hopp, K Lunde, et al.
Pageof 17